eNauka - pregled
Pregled prema Autor Vitezić, Dinko
Prikaz rezultata 1 do 4 od 4
| Godina | Naslov | Autor(i) | Tip rezultata | Mp-kat. |
|---|---|---|---|---|
| 2025 | Cost-utility analysis of nusinersen–risdiplam switch in patients with spinal muscular atrophy in Croatia: A discrete event simulation model | Belančić, Andrej; Stević, Ivana   ; Gkrinia, Elvira Meni Maria; Vitezić, Dinko; Janković, Slobodan | Article | 21M21 |
| 2025 | Costs of Treating Onasemnogene Abeparvovec-Xioi-Induced Liver Injury | Belančić, Andrej; Raičević, Branislava; Stević, Ivana ; Vitezić, Dinko; Janković, Slobodan M. | Article | 22M22 |
| 2025 | Diverging Safety Signals: A Trend Analysis of Suspected Adverse Drug Reactions Reporting for Spinal Muscular Atrophy Therapies in the European Union | Belančić, Andrej; Mas, Petar; Stević, Ivana ; Vitezić, Dinko; Janković, Slobodan | Article | 21M21 |
| 2026 | The evolving therapeutic landscape of spinal muscular atrophy – A scoping review of investigational agents, emerging delivery technologies and strategic innovations | Belančić, Andrej; Eustaquio, Patrick; Gkrinia, Elvira Meni Maria; Stević, Ivana ; Javor, Eugen; Lam, Yun Wah; Janković, Slobodan ; Vitezić, Dinko | Naučni članak | 21M21 - Vodeći međunarodni časopis kategorije M21 |